Literature DB >> 28359058

Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis.

Mohammad Ali Sahraian1, Saeed Rezaali, Melina Hosseiny, Rozita Doosti, Ali Tajik, Abdorreza Naser Moghadasi.   

Abstract

BACKGROUND/AIMS: To determine the effect of sleep disturbances on predisposing multiple sclerosis (MS) patients for acute relapse.
METHODS: This case-control study was conducted on 80 MS patients including 40 patients in the remission phase and 40 in the relapse phase. Patients were asked to fill in the Pittsburgh Sleep Quality Index to determine their sleep quality during the previous month. Individuals with scores of 5 or less were considered having normal sleep quality.
RESULTS: Mean ± SD ages were 32.5 ± 7.7 and 30.2 ± 7.2 years among patients with and without acute relapses, respectively (p > 0.05). The mean disease duration and disease severity (according to Expanded Disability Status Scale [EDSS]) were comparable across the groups (p > 0.05). Among those with and without acute exacerbations, 87.5 and 50% had poor sleep quality, respectively (p = 0.0001), with OR of 1.75 (95% CI 1.25-2.43). The age, gender, EDSS, and disease duration did not associate with sleep quality in either groups (p > 0.05).
CONCLUSIONS: This study showed that sleep disturbance might be a trigger for an acute MS exacerbation. Increasing the awareness of specialists and routine screening of sleep disorders in MS patients are warranted, as treatment of these disorders might decrease the likelihood of acute relapses.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Multiple sclerosis; Pittsburgh Sleep Quality Index; Relapse; Sleep disorder

Mesh:

Year:  2017        PMID: 28359058     DOI: 10.1159/000470904

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

Review 1.  Multiple Sclerosis: Systemic Challenges to Cost-Effective Care.

Authors:  David R Weinstein; Gary M Owens; Ankit Gandhi
Journal:  Am Health Drug Benefits       Date:  2022-03

2.  Self-report sleep quality combined with sleep time variability distinguishes differences in fatigue, anxiety, and depression in individuals with multiple sclerosis: A secondary analysis.

Authors:  Catherine F Siengsukon; Mohammed Alshehri; Mayis Aldughmi
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-12-12

3.  Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments.

Authors:  Cihat Uzunköprü; Yeşim Beckmann
Journal:  EPMA J       Date:  2019-08-10       Impact factor: 6.543

4.  Sleep Disturbances, Degree of Disability and the Quality of Life in Multiple Sclerosis Patients.

Authors:  Aleksandra Kołtuniuk; Magdalena Kazimierska-Zając; Dominika Pogłódek; Justyna Chojdak-Łukasiewicz
Journal:  Int J Environ Res Public Health       Date:  2022-03-10       Impact factor: 3.390

5.  Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study.

Authors:  Rozita Doosti; Abdorreza Naser Moghadasi; Amir Reza Azimi; Shahrokh Karbalai Saleh; Masoud Etemadifar; Vahid Shaygannejad; Fereshteh Ashtari; Mohammad Hossein Harirchian; Seyed Bahaadin Siroos; Hormoz Ayramloo; Nastaran Majdinasab; Seyyed Mohammad Masood Hojjati; Nabiollah Asghari; Seyed Mohammad Baghbanian; Hamed Cheraghmakani; Mahmoud Abedini; Behnaz Sedighi; Negar Mohseni Abbas Abadi; Maedeh Ghasemitabar; Sara Talebianpour; Tohid Babayi Daylari; Vahid Dana; Neda Ghaleh Noie; Mohammad Ali Sahraian
Journal:  Caspian J Intern Med       Date:  2021-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.